Viewing nowCoska Tablet 100 mg (Losartan Potassium)
Losartan Potassium 100mg
Tablet · Prescription medication
SK Chemical Co., Ltd.

MFDS item code 200803211 · Notified 2008.03.21 · Insurance code 644703420
Treatment of kidney disease in patients with hypertension or type 2 diabetes accompanied by hypertension
This medication is used to effectively control blood pressure in patients with hypertension. It offers renal protective effects, especially in patients with type 2 diabetes-related hypertension, helping to delay the progression of kidney disease. This, in turn, reduces the risk of cardiovascular diseases and prevents the deterioration of kidney function. This medication is effective in preventing and treating various complications associated with hypertension.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium taken orally once daily. The maximum blood pressure-lowering effect occurs 3 ~ 6 weeks after starting treatment. If the response is inadequate, the same total daily dose may be divided and taken orally twice daily, or the dose may be increased to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Treatment of renal disease in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients: No initial dose adjustment is required in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is required. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. 3) Patients with reduced effective circulating blood volume For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg once daily is recommended (see Precautions). 4) Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Children and adolescents aged 6 years and older: (1) Patients weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg once daily; it may be increased to a maximum of 50 mg once daily according to the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. (3) Not recommended for children under 6 years of age, children with a glomerular filtration rate below 30mL/min/1.73㎡, or children with hepatic impairment.
This medication should not be taken during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Use during pregnancy may hinder fetal lung development or lead to dangerous side effects such as skeletal malformations and kidney dysfunction. Patients with allergic reactions to this medication, severe liver disease, certain genetic lactose intolerance disorders, pregnant women, or women who may become pregnant should not take it. Additionally, patients with severe kidney impairment or a history of angioedema should avoid its use. Older adults, patients with hyperkalemia, or liver impairment should use this medication with caution, as regular monitoring is necessary to avoid excessively low blood pressure or worsening kidney function. Side effects such as dizziness, fatigue, cough, indigestion, muscle pain may occur; any unusual symptoms should prompt consultation with healthcare professionals. Due to the hypotensive effects, symptoms of fainting or low blood pressure may occur, so extra care is required when starting treatment or increasing dosage. This medication, when taken with other antihypertensives, potassium-sparing diuretics, or potassium supplements, may result in dangerously high blood potassium levels; therefore, it should be taken upon consultation with a physician. This medication can affect liver and kidney function, so patients with liver or kidney disease should inform healthcare professionals prior to use and routinely check their condition. It is advisable for pregnant or breastfeeding women to refrain from using this medication; if absolutely necessary, breastfeeding should be discontinued. This medication is not indicated for children, especially those under 6 years old or those with significantly reduced kidney function. Regular blood pressure and blood tests should be conducted during the medication period, and any unusual symptoms should be reported to a doctor immediately. It is best to avoid grapefruit juice while taking this medication, and caution is advised when driving or operating machinery due to potential dizziness. In cases of overdose, symptoms may include hypotension and heart rhythm abnormalities, and immediate medical treatment is required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safest to store it at room temperature between 1 to 30 degrees Celsius. Therefore, it is important to avoid direct sunlight and store it at appropriate temperatures to maintain its effectiveness.
White oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 100mg
Tablet · Prescription medication
SK Chemical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.